Bendamustine in the treatment of non-Hodgkin’s lymphomas

PURPOSE: To review available data using bendamustine alone and in combination with other chemotherapeutic agents in treatment of patients with non-Hodgkin’s lymphomas. METHODS: Internet database searches and literature review. RESULTS: Bendamustine was approved in March 2008 by the United States Foo...

Descripción completa

Detalles Bibliográficos
Autores principales: Hagemeister, Fredrick, Manoukian, George
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886317/
https://www.ncbi.nlm.nih.gov/pubmed/20616914

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2886317/
https://www.ncbi.nlm.nih.gov/pubmed/20616914

Ejemplares similares